Serum creatine:ATP phosphotransferase (CPK) was raised more frequently in positive cases and lessfrequently in negative cases than the other enzymes assayed, and the extent of increase in the former was much the highest relative to the upper normal limit for that enzyme. Serum a-hydroxybutyrate dehydrogenase (HBD) activity showed more modest increases in positive cases, f-and was raised at some point during investigation in I5 per cent of negative cases, but was especially valuable in confirming the diagnosis in patients presenting more than 72 hours after onset of symptoms. Aspartate aminotransferase activity of serum was difficult to interpret unless alanine .-aminotransferase activity was also known; even then the information did not always justify the effort ofmaking these estimations routinely additional to those ofserum CPK and HBD activities.
The raised levels of serum enzymes in man subsequent to acute myocardial infarction have been well documented. Those most commonly used in routine diagnosis at the present time include aspartate aminotransfer-,->ase (LaDue, Wroblewski, and Karmen, I954) , creatine:ATP phosphotransferase (Dreyfus et al., i960) , and the fast cationic fractions of lactate dehydrogenase characterized by ftheir ability to catalyse the reduction of 2-oxobutyrate and designated 'a-hydroxybutyrate dehydrogenase activity' (Rosalki and laboratory diagnosis is intended to provide a more realistic assessment of the merits and limitations of these tests in assisting the diagnosis of myocardial infarction in a general hospital population.
Materials and methods
All samples submitted to this laboratory for determination of serum enzymes in cases where a diagnosis of myocardial infarction was suspected were analysed in respect of the period from i June I968 tO 3I August 1970. The patients were drawn from all hospitals within the United Sheffield Hospitals Group, and some were referred from general practices and peripheral hospitals in the vicinity. The determinations were carried out by the following techniques: aspartate aminotransferase (GOT) and alanine aminotransferase (GPT) by semiautomated kinetic procedures giving normal ranges of 5-40 and 5-30 International Units per litre (IU/1.) respectively at 37°C (Ellis and Goldberg, 1970) ; creatine: ATP phosphotransferase (CPK) by a colorimetric assay with normal range 15-70 IU/l. at 37'C (Worthy, Whitehead, and Goldberg, 1970) ; and a-hydroxybutyrate dehydrogenase (HBD) by a fully automated procedure utilizing absorbance change at 340 nm and yielding a normal range of IU/1. at 250C (Hirst and Goldberg, I970) . On the basis of the details on the laboratory request form, patients were placed by us in a 'cardiac investigation stream' and the following protocol was observed: on the first sample, which medical staff were encouraged to take at the earliest possible opportunity even if this lay outside normal laboratory hours, all 4 enzyme determinations were carried out and a request sent to the ward or the practitioner for a second specimen exactly 24 hours after the first. On the second sample, all determinations except GPT activity were carried out as a routine; GPT activity was determined only if the aminotransferase ratio of the initial sample raised the possibility of hepatic involvement, i.e. GPT: GOT> I-0. A third sample was routinely sought 24 hours after the second and HBD activity determined; if the results of the earlier samples were inconsistent or in conflict with the diagnosis, all 4 enzymes were assayed, and if necessary further samples requested or the assays on the earlier samples repeated.
One to two weeks later, the medical staff were contacted with a view to classifying the patient into one of the following 4 categories, and in doing so they were asked not to take account of the enzyme results. I) Positive To qualify for this group, serial electrocardiographic exminations on the patient had to provide convincing evidence of myocardial infarction; and clinical support in the form of characteristic pain, shock, hypotension, and increase in temperature, white cell count, and ESR was required.
2) Clinically positive Patients in this category had all the clinical features present in the above group, and these features could not be explained on grounds other than myocardial infarction despite careful investigation. But serial electrocardiograms yielded negative or equivocal conclusions, often because of abnormalities persisting from previous episodes of myocardial infarction. 3) Electrocardiogram positive Patients in this category presented unequivocal evidence of recent myocardial infarction on electrocardiographic examination, but the clinical features of infarction were lacking. Pain was neither characteristic of infarction nor prominent among the patient's complaints, and in many cases the diagnosis was reached in the course of investigating unexplained cardiac failure, arrhythmia, hypotension, or embolism. In many cases within this group, the precise time of myocardial infarction could not be ascertained.
4) Negative
The clinical features in these patients were rarely pathognomonic of infarction though the latter condition had to be considered in the differential diagnosis. In most cases a final diagnosis other than that of myocardial infarction provided an adequate basis for the clinical picture, and the electrocardiograms gave normal or equivocal results.
Cases placed by the medical staff in the first category, in which raised levels of CPK, HBD, and GOT were obtained in at least one specimen, and where GPT activity was normal or only slightly raised, were accepted as correctly diagnosed. Cases placed in the fourth category, in which enzyme tests were consistently normal, or where an isolated rise in GPT was the only abnormality, were likewise accepted as correctly diagnosed. All other cases in these two categories, as well as all cases in the second and third categories, were checked by us retrospectively to ensure that the diagnosis was correct and to ascertain a possible reason for the anomalous enzyme results. Approximately 850 case records were checked in this way and about i in io had to be reclassified because of obvious errors in the information originally provided to us. Special attention was given to estimating the time of onset of symptoms in the positive cases. The assessment of the medical staff on this point was accepted after detailed discussion, though here too the information was subsequently checked in the case records if it conflicted with the enzyme results.
Results
Positive cases A total of 807 cases fell into this category of which 750 had at least one blood sample drawn between 12 and 72 hours after onset of symptoms. The distribution of results for the enzyme determinations based upon the highest value for each is shown, in respect of these 750 cases (Fig. i) . CPK activity was the most sensitive index of response to infarction in that 46 per cent of the cases had on at least one occasion a value more than seven times the upper normal limit, and only 7 per cent failed to show raised activity in any sample. With GOT, 21 per cent of the cases had a value greater than 7.5 times the upper normal limit, and 7 per cent failed to show raised activity in any sample, but 5 per cent of cases with raised GOT had even higher values for GPT in the same sample and were thus classified as having equivocal aminotransferase results. HBD was least sensitive, only 37 per cent of the cases yielding values more than 2-5 times the upper normal limit, and in 9 per cent all values were normal.
All three enzymes were normal in 3 per cent of the cases (Table i ) and all three were raised in 82 per cent; this latter figure rose to 85 per cent, if cases with high GPT activity were included. I3 (o-8) II27 (72X6) and electrocardiographic criteria * Refers to cases in whom both aminotransferases were raised, but GPT > GOT. Surgical operations and cerebrovascular accidents were associated predominantly with raised CPK activity, but the incidence of raised GOT and HBD in these conditions was far from negligible. Pulmonary embolism is listed as a separate entity, HBD elevation being mainly implicated. In many cases, the cause of a raised HBD activity was ascribed to haemolysis of the sample, and in a few, where a second episode was suspected but disproved, to persisting rises from an episode of infarction within the previous two weeks; a few subjects with raised HBD activity were found to be uraemic. The diagnosis in cases grouped as 'other diseases' included cancer, leukaemia, and renal disease without uraemia.
Unclassified One hundred and twenty-four cases could not be classified. In the main, these were patients with equivocal electrocardiographic patterns and conflicting clinical features which only partly fulfilled the criteria for inclusion in the second category, and which could not be fitted into a clear-cut alternative diagnosis. The data on these subjects were not analysed.
Discussion
The data in this report extend observations recorded for the first 6-month period covered by this investigation (Goldberg, I97I) . The conclusion then reached was that great caution was needed in interpreting enzyme chan- 238 * Refers to cases in which both aminotransferases were raised, but GPT > GOT.
t Includes asthma and status asthmaticus, chronic bronchitis, and emphysema without heart failure, broncho-and lobar pneumonia, and pulmonary tuberculosis.
t Includes cancer, leukaemia, and renal disease without uraemia.
accident (5), severe pyrexia associated with bacteraemic shock (3), pericarditis (3), major operation (3), cardiac arrhythmia (2), drug overdose (2), myxoedema with coma (i), pulmonary embolism (i), and epilepsy (i). In most of these conditions, enzyme tests will be of value only in so far as consistently normal results will help to exclude myocardial infarction. The detailed analysis of those cases in the fourth category in which raised enzyme activities were found (Table 2) provides further information for assessing the limitations of the individual tests, and the distribution of these abnormalities in different diseases conforms broadly to the experience of those authors cited in Table 3 . In particular, the lack of specificity of increases in GOT has been well recognized (Wroblewski, I958, 1959) . This makes it imperative to have simultaneous measurement of GPT activity; if this exceeds GOT activity, it points to the presence of an intra-abdominal lesion or hepatic involvement as the likely explanation for the raised GOT, and as shown in Table 2 helps to eliminate many of the false-positive results for GOT that might otherwise be accepted. On the other hand, the injudicious application of this principle would also require the setting aside Table I as 'equivocal'. after the onset of symptoms. This value is diminished somewhat by the high incidence of abnormal results in patients known not to have sustained myocardial infarction; but it must be emphasized that the normal ranges for these enzymes embrace only 95 per cent of the normal population, so that 2 5 per cent of normal subjects would be expected to exceed the upper limit. The data compiled in Table 2 therefore indicate those conditions most frequently associated with raised enzyme levels without implying that these conditions are responsible for the increases. Moreover, the protocol followed in the routine investigation of these patients was such that HBD was estimated much more frequently than the other enzymes, and therefore spurious in- 
